136677-03-7

Upstream product

• 136677-02-6 (S)-4,5,6,7-tetrahydro-1-<(3-methyl-4-nitrophenyl)methyl>-1H-imidazo<4,5-c>pyridine-6-carboxylic acid dihydrochloride 
• 149-73-5 trimethyl orthoformate 
• 20898-43-5 4-(2-tert-butoxycarbonylamino-2-methoxycarbonyl-ethyl)-1H-imidazole-1-carboxylic acid tert-butyl ester 
• 114787-84-7 3-<(3-methyl-4-nitrophenyl)methyl>-L-histidine dihydrochloride 
• 114787-83-6 N-<(1,1-dimethylethoxy)carbonyl>-3-<(3-methyl-4-nitrophenyl)methyl>-L-histidine methyl ester 
• 80866-75-7 3-methyl-4-nitrobenzyl alcohol 

Downstream Products

• 114785-70-5 (S)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1-<(3-methyl-4-nitrophenyl)methyl>-1H-imidazo<4,5-c>pyridine-6-carboxylic acid methyl ester 
• 124597-33-7 (S)-5-diphenylacetyl-1-(3-methyl-4-nitrophenyl) methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid 
• 136676-91-0 PD 123319 bistrifluoroacetate 
• 114785-87-4 5-(diphenylacetyl)-4,5,6,7-tetrahydro-1-<<3-methyl-4-<<(methylamino)carbonyl>amino>phenyl>methyl>-1H-imidazo<4,5-c>pyridine-6-carboxylic acid 
• 150371-65-6 (S)-1-(4-Acetylamino-3-methyl-benzyl)-5-diphenylacetyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid methyl ester 
• 114785-67-0 (S)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1-<(3-methyl-4-nitrophenyl)methyl>-1H-imidazo<4,5-c>pyridine-6-carboxylic acid 
• 114785-86-3 (S)-1-(4-Acetylamino-3-methyl-benzyl)-5-diphenylacetyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid 
• 114787-66-5 1-[(S)-6-Hydroxymethyl-1-(3-methyl-4-nitro-benzyl)-1,4,6,7-tetrahydro-imidazo[4,5-c]pyridin-5-yl]-2,2-diphenyl-ethanone 
• 136677-04-8 (S)-1-<(4-amino-3-methylphenyl)-methyl>-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo<4,5-c>pyridine-6-carboxylic acid, methyl ester 
• 136676-90-9 (+)-PD 123177 

Relevant academic research and scientific papers

4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid amide

Disclosed herein are 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid amide derivatives having a high antagonistic activity against angiotensin II and a high specificity to angiotensin II receptors, intermediates for preparing the derivative

Synthesis and Structure-Activity Relationships of a Novel Series of Non-Peptide Angiotensin II Receptor Binding Inhibitors Specific for the AT2 Subtype

Structure-activity relationships are reported for a novel class of 4,5,6,7-tetrahydro-1H-imidazopyridine-6-carboxylic acid derivatives that displace 125I-labeled angiotensin II from a specific subset of angiotensin II (Ang II) binding sites in rat